Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 313
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02064556 | CKD-330 Drug-Drug Interaction Study (Amlodipine) | ||
| NCT03246880 | Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients | ||
| NCT01842269 | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients | ||
| NCT02548286 | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs | ||
| NCT05881213 | Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults | ||
| NCT01496261 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT02494284 | Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation | ||
| NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
| NCT06916793 | A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT03569579 | CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) | ||
| NCT02648854 | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | ||
| NCT03583905 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet | ||
| NCT04667975 | The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy | ||
| NCT05549401 | Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 | ||
| NCT05043467 | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus | ||
| NCT05526742 | A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects | ||
| NCT01956201 | Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin | ||
| NCT06709807 | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers | ||
| NCT04676893 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects | ||
| NCT02066207 | CKD-337 Drug Interaction Study | ||
| NCT04083872 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) | ||
| NCT05587699 | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A | ||
| NCT07258745 | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants | ||
| NCT02002611 | Drug-drug Interaction Study(Lobeglitazone, Warfarin) | ||
| NCT01019941 | Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer | ||
| NCT04448223 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT02565368 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers | ||
| NCT04345796 | Pharmacological Reduction of Right Ventricular Enlargement | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study | ||
| NCT02805738 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet | ||
| NCT04840745 | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT04102943 | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. | ||
| NCT03627182 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT06695572 | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT06627322 | A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | ||
| NCT02005744 | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function | ||
| NCT02827890 | CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) | ||
| NCT06430047 | Efficacy and Safety of EsoDuo® | ||
| NCT04883658 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) | ||
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | ||
| NCT04019743 | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers | ||
| NCT06204107 | A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 | ||
| NCT05741437 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 | ||
| NCT01756430 | Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension | ||
| NCT03346187 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 |
